Delivery Order SPE2DB22D1106-SPE2DB24FELU2
Award Date
4/16/24
Potential Completion Date
4/17/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $1,885.04 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Quillivant XR 25 mg/5 ml suspension in 180 ml bottles. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary contract vehicle for the company to deliver...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,344.65 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide the medication Quillivant XR 25 mg/5 ml suspension in 150 ml bottles. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical. The IDC serves as a vehicle for the company to supply a broad range of pharmaceutical products and...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,013.72 to Amerisourcebergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product, with a completion date of February 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor and is responsible for delivering the requested medication to the government. This...
The Defense Logistics Agency (DLA) awarded a $3,188.50 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, to provide 180 ml of Quillivant XR 25 mg/5 ml suspension. This order is part of Amerisourcebergen's $999,999,999.00 indefinite delivery contract with DLA to deliver a comprehensive range of medications and medical supplies to support the Department of Defense's military treatment programs and facilities worldwide. The delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical company. The contract is for the supply of Quillivant XR 25 mg/5 ml suspension, 120 ml, with a potential value of $1,270.30 and a completion date of February 9, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide a specialty medication, QUILLIVANT XR 25 mg/5 ml suspension, 150 ml. The contract has a ceiling value of $2,008.79 and a performance period through April 4, 2024. This delivery order contract is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp by DLA,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,609.81 firm fixed-price delivery order is for the drug Quillivant XR 25 mg/5 ml suspension, with a period of performance through March 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, running through November 2026, which serves as a primary...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Quillivant XR 25 mg/5 ml suspension in a 120 ml bottle. The order, valued at $1,524.36, has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order is part of a larger indefinite delivery contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.84 Firm Fixed Price Delivery Order is for the supply of Quillivant XR 25 mg/5 ml suspension, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, valued at $1,524.36, is for the supply of QUILLIVANT XR 25 MG/5 ML SUSP 150ML, a pharmaceutical product. This delivery order is placed under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp,...